FeesSafety
Pluang+

Vishay Precision Group reports Q3 revenue of $87.4M with strong orders over $100M, driven by AI and aerospace demand.

Company Fundamentals
04 Nov 2026, 13:15 WIB
GlobeNewsWire
View Source
Bullish
Vishay Precision Group reports Q3 revenue of $87.4M with strong orders over $100M, driven by AI and aerospace demand.

Vishay Precision Group posted adjusted Q3 fiscal 2026 revenue of $87.4 million, up 9.6% year-over-year, supported by record sensor bookings exceeding $51 million and total orders surpassing $100 million. Growth was driven by demand in AI-driven applications, semiconductor equipment, data centers, aerospace, and defense markets. Despite currency headwinds and higher costs impacting margins and earnings per share, the company expects continued revenue momentum into 2027 and plans to realize operating leverage from rising sales. Cost-saving initiatives targeting $6 million in 2026 are on track, and the company is preparing for increased production of humanoid robots aligned with customer schedules.

Vishay Precision Group's Q3 revenue and orders offer context for readers. For those tracking Technology-sector US stocks on Pluang, 91 of 150 rose and 53 fell as of Nov 04, 2026 16:41 WIB. Notable movers include SMCI at USD 33.68 (+7.30%, 21 days typical hold, 27% Sell / 73% Buy), AMD at USD 516.00 (+6.63%, 93 days typical hold, 58% Sell / 42% Buy), and XYZ at USD 80.78 (+6.33%, 78 days typical hold, 100% Sell / 0% Buy).

More News

Kelly Technology + Motion Recruitment named Leader by Everest Group for US IT staffing and consulting excellence

Kelly Technology + Motion Recruitment named Leader by Everest Group for US IT staffing and consulting excellence

Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...

Market News
Bullish
32 minutes ago
Sutro Biopharma to present at multiple investor conferences in November and December 2026

Sutro Biopharma to present at multiple investor conferences in November and December 2026

Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...

Market News
Neutral
1 hour ago
etoro acquires Argentine fintech LB Finanzas to expand in Latin America

etoro acquires Argentine fintech LB Finanzas to expand in Latin America

etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...

Company Fundamentals
Bullish
1 hour ago
JD.com to release Q3 2026 financial results on Nov 17 with a management call scheduled.

JD.com to release Q3 2026 financial results on Nov 17 with a management call scheduled.

JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...

Company Fundamentals
Neutral
4 hours ago
KE Holdings to release Q3 2026 financial results on Nov 16 with a live earnings call.

KE Holdings to release Q3 2026 financial results on Nov 16 with a live earnings call.

KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App